Our study demonstrates that in ccRCC, S100A2 functions as a cofactor assisting the transcription factor HNF1A in promoting GLUT2 expression, thereby enhancing glycolysis and driving tumor progression. Here, S100A2 is linked to nonpapillary renal cell carcinoma.